PlainPharmaWatch

CMS Open Payments · Program Year 2024

New Mexico

New Mexico received $6,708,475.48 in pharmaceutical-industry payments to 3,352 physicians and 9 teaching hospitals across 50,758 transactions.

$6.7M
Total payments
$5.6M
To physicians
$456.0K
To teaching hospitals
#45
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $6.7M in payments to 3,352 physicians and 9 teaching hospitals in New Mexico. That ranks New Mexico #45 of 59 states and territories (0.0% of the US total), averaging $1.7K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

New Mexico pairs below-median payment volume with a physician-heavy payment mix.

#45
of 59 states
0.0%
of the national total
82.9%
to physicians vs. hospitals
3,352
physicians paid

What the Data Shows for New Mexico

New Mexico sits in the lower-volume tercile at #45 of 59 (0.0% of US dollars). The PY2024 file still records $6,708,475.48 across 50,758 transactions.

Physician versus hospital mix is near the corpus middle (82.9% / 6.8%). Average transaction $132.17. Leading nature of payment: "Compensation for Services Other Than Consulting" at $1.8M (27.1% of the state file; top-three natures 67.4%).

New Mexico sits in the 25th percentile (lower-volume tier). Just above: South Dakota ($7.3M). Just below: Delaware ($4.3M). For context: top-ranked California ($342.4M) is 51.0× larger than New Mexico. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in New Mexico are distributed between physicians and teaching hospitals.

Physician Payments

$5.6M

82.9% of total · 3,352 recipients · $1.7K avg

Teaching Hospital Payments

$456.0K

6.8% of total · 9 hospitals · $50.7K avg

Payment Breakdown by Type

New Mexico has 14 types of pharmaceutical payments. "Compensation for Services Other Than Consulting" accounts for 27.1%.

Nature concentration in New Mexico

Top three Open Payments natures are 67.4% of state dollars; residual is every other reported nature

Compensation for Services Ot…$1.8MFood and Beverage$1.4MConsulting Fee$1.3MAll other natures (11)$2.2M

Payment categories in New Mexico

Top categories by total reported dollar volume

1. Compensation for Services…$1.8M2. Food and Beverage$1.4M3. Consulting Fee$1.3M4. Travel and Lodging$724.5K5. Education$546.6K6. Long-Term Medical Supply …$289.0K7. Royalty or License$172.6K8. Honoraria$130.0K9. Compensation for Faculty …$120.1K10. Space Rental or Facility…$85.1K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $1.8M 577
Food and Beverage $1.4M 45,798
Consulting Fee $1.3M 593
Travel and Lodging $724.5K 2,446
Education $546.6K 781
Long-Term Medical Supply or Device Loan $289.0K 160
Royalty or License $172.6K 25
Honoraria $130.0K 53
Compensation for Faculty or Speaker (Medical Education) $120.1K 37
Space Rental or Facility Fees $85.1K 43
Grant $48.4K 11
Gift $38.1K 184
Debt Forgiveness $32.0K 18
Entertainment $2.7K 32

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What New Mexico totals can and cannot tell you

The aggregate payment figure for New Mexico measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download New Mexico's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.